MaryLouSchmidtMD

PubMed

• 1 citations
  Conjunctival and periorbital petechiae presumed secondary to self-inflicted asphyxiation in a pediatric patient.
  Aaron R. Kaufman, Daniel J. Oh, Ariel Gliksberg, Mary Lou Schmidt, Mehmet C. Mocan> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2021 Jan 31
• 7 citations
  A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities
  Nupur Mittal, Jonathan Davidson, Mario F Martinez, Reynaldo Sanchez, Nitin Sane, Lisa Giordano, Daniel K. Choi, Paul Kent, Asneha Iqbal, Cathleen Kiely, Kathleen Breen...> ;Journal of Adolescent and Young Adult Oncology. 2019 Jun 4
• Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.
  Abara, W. E.,Spradling, P.,Zhong, Y.,Moorman, A.,Teshale, E. H.,Rupp, L.,Gordon, S. C.,Schmidt, M.,Boscarino, J. A.,Daida, Y. G.,Holmberg, S. D.> ;J Gastrointest Cancer. 2019 May 28
• 35 citations
  Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
  Clare J. Twist, Arlene Naranjo, Mary Lou Schmidt, Sheena C. Tenney, Susan L. Cohn, Holly J. Meany, Peter Mattei, E. Stanton Adkins, Hiroyuki Shimada, Wendy B. London, ...> ;Journal of Clinical Oncology. 2019 Jan 10
• 6 citations
  Thrombocytopenia and Predisposition to Acute Myeloid Leukemia due to Mosaic Ring 21 with Loss of RUNX1: Cytogenetic and Molecular Characterization
  Erica Vormittag-Nocito, Hongyu Ni, Mary Lou Schmidt, Valerie Lindgren> ;Molecular Syndromology. 2018 Nov 9
• 31 citations
  Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review.
  Kelly Liesse, Jamie Harris, Megan Chan, Mary Lou Schmidt, Bill Chiu> ;Journal of Pediatric Hematology/oncology. 2018 Aug 1
• 34 citations
  Exploring intentions of physician-scientist trainees: factors influencing MD and MD/PhD interest in research careers
  Jennifer M. Kwan, Dania Daye, Mary Lou Schmidt, Claudia Morrissey Conlon, Hajwa Kim, Bilwaj Gaonkar, Aimee S. Payne, Megan Riddle, Sharline Madera, Alexander J. Adami,...> ;BMC Medical Education. 2017 Jul 11
• 5 citations
  Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy
  Nupur Mittal, Vinay K. Aakalu, Sangeeta Mehendele, Pete Setabutr, Edward A. Michals, Mary Lou Schmidt> ;Journal of Pediatric Hematology/oncology. 2016 Jul 27
• 5 citations
  Chemotherapy in Children with Head and Neck Cancers Perspectives and Review of Current Therapies
  Daniel K. Choi, Mary Lou Schmidt> ;Oral and Maxillofacial Surgery Clinics of North America. 2016 Feb 1
• 13 citations
  Health behaviors of minority childhood cancer survivors
  Melinda R. Stolley, Lisa K. Sharp, Christy C. Tangney, Linda Schiffer, Claudia Arroyo, Yoonsang Kim, Richard T. Campbell, Mary Lou Schmidt, Kathleen Breen, Karen E. Ki...> ;Cancer. 2015 May 15
• 2 citations
  A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease.
  Nupur Mittal, Bing Zhu, Sujata Gaitonde, Yang Lu, Mary Lou Schmidt> ;Pediatric Blood & Cancer. 2015 May 1
• 9 citations
  Electronic Personal Health Records for Childhood Cancer Survivors: An Exploratory Study.
  Lisa K. Sharp, Priscilla Carvalho, Matthew W. Southward, Mary Lou Schmidt, Leslie N. Jabine, Melinda R. Stolley, Ben S. Gerber> ;Journal of Adolescent and Young Adult Oncology. 2014 Sep 12
• 54 citations
  Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0...
  Clare J. Twist, Mary Lou Schmidt, Arlene Naranjo, Wendy B. London, Sheena C. Tenney, Araz Marachelian, Hiroyuki Shimada, Margaret H. Collins, Natia Esiashvili, E. Stan...> ;Journal of Clinical Oncology. 2014 May 20
• 66 citations
  Ototoxicity in Children With High-Risk Neuroblastoma: Prevalence, Risk Factors, and Concordance of Grading Scales—A Report From the Children's Oncology Group
  Wendy Landier, Kristin Knight, F. Lennie Wong, J. C. K. Lee, Ola Thomas, Heeyoung Kim, Susan G. Kreissman, Mary Lou Schmidt, Lu Chen, Wendy B. London, James G. Gurney> ;Journal of Clinical Oncology. 2014 Feb 20
• 102 citations
  A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
  Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt, Arlene Naranjo, Patrick McGrady, James D. Geiger, Lisa Diller, Mary Lou Schmidt, John M. Maris, Susan L. Cohn, Ro...> ;Annals of Surgery. 2012 Oct 1
• 8 citations
  Discordant parent reports of family functioning following childhood neuroblastoma: a report from the children's oncology group.
  Catherine C. Peterson, Melissa K. Cousino, Janet E. Donohue, Mary Lou Schmidt, James G. Gurney> ;Journal of Psychosocial Oncology. 2012 Jun 28
• 97 citations
  Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
  Douglas Strother, Wendy B. London, Mary Lou Schmidt, Garrett M. Brodeur, Hiroyuki Shimada, Paul S. Thorner, Margaret H. Collins, Edward P. Tagge, Stanton Adkins, C. Pa...> ;Journal of Clinical Oncology. 2012 May 20
• 49 citations
  Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
  Denah R. Taggart, Wendy B. London, Mary Lou Schmidt, Steven G. DuBois, Tom Monclair, Akira Nakagawara, Bruno De Bernardi, Peter F. Ambros, Andrew D.J. Pearson, Susan L...> ;Journal of Clinical Oncology. 2011 Nov 20
• 186 citations
  Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
  David L. Baker, Mary Lou Schmidt, Susan L. Cohn, John M. Maris, Wendy B. London, Allen Buxton, Daniel O. Stram, Robert P. Castleberry, Hiroyuki Shimada, Anthony D. San...> ;The New England Journal of Medicine. 2010 Sep 30
• 15 citations
  Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation
  Greta R. Bunin, Marc A. Felice, William Davidson, Debra L. Friedman, Carol L. Shields, Andrew D. A. Maidment, Michael J. O'Shea, Kim E. Nichols, Ann Leahey, Ira J. Dun...> ;International Journal of Cancer. 2011 May 15
• 4 citations
  Conjunctival marginal zone b-cell lymphoma in a 13-year-old child.
  Shahar Frenkel, Sujata Gaitonde, Nathalie F. Azar, Michael G. Wood, Mary Lou Schmidt> ;Journal of Pediatric Ophthalmology and Strabismus. 2010 May 21
• 5 citations
  Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report
  Ulf H. Beier, Mary Lou Schmidt, Howard Hast, Susan A. Kecskes, Leonard A. Valentino> ;Journal of Medical Case Reports. 2010 Mar 19
• 1 citations
  Online ethics discussion forum facilitates medical center clinical ethics case reviews.
  David Ramsey, Mary Lou Schmidt, Lisa Anderson-Shaw> ;JONA'S Healthcare Law, Ethics and Regulation. 2010 Jan 1
• 4 citations
  Prolonged chronic phase of greater than 10 years of chronic myelogenous leukemia in a patient with congenital human immunodefeciency virus infection
  Bhuvana A. Setty, Karen C. Hayani, Bruce I. Sharon, Mary Lou Schmidt> ;Pediatric Blood & Cancer. 2009 Oct 1
• 8 citations
  Pediatric squamous cell carcinoma arising in an alpha-fetoprotein-producing mature cystic teratoma of the mandible.
  Robert J. Cabay, Suman Setty, Joel L. Schwartz, Mike Yao, Mary Lou Schmidt, Sara C. Gordon> ;Pediatric Blood & Cancer. 2009 Jan 1
• Join now to see all

Journal Articles

• Ototoxicity in Children with High Risk Neuroblastoma-Prevalence, Risk Factors and Concordance of Grading Scales: A Report from the Children’s Oncology Group.  
  Landier W, Knight K, Wong L, Lee J, Thomas O, Kiim H, Kreissman S, Schmidt ML, Chen L, London W, Gurney J, Bhatia S, Journal of Clinical Oncology, 5/1/2013
• A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants: A Children’s Oncology Group Study.  
  Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, Diller L, Schmidt ML, Maris JM, Cohn SL, Shamberger RC, Annals of Surgery, 10/1/2012
• Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients with Low-Risk Neuroblastoma: Results of Children’s Oncology Group Study P9641.  
  Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, Murray K, Lavey RS, Matthay KK, Castleberry R, Maris..., Journal of Clinical Oncology, 4/23/2012
• Prognostic value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients with Metastatic Neuroblastoma diagnosed between birth and 18 months.  
  Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair T, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK, Journal of Clinical Oncology, 11/1/2011
• Ototoxicity in childrens with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales-A report from the Children’s Oncology Group.  
  Landier W, Knight KR, Wong FL, Lee JK, Thomas O, Kim H, Kreissman SG, Schmidt ML, Chen L, London WB, Bhatia S, Gurney JG, J Clin Oncol, 1/1/2011
• Biologically-based therapy reduction for intermediate-risk neuroblastoma: Children’s Oncology Group Study A3961.  
  Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Seeger RC, Matthay KM, New England Journal of Medicine, 9/30/2010
• Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation  
  Bunin GR, Felice MA, Davidson W, Friedman DL, Shields CL, Maidment A, O’Shea M, Nichols KE, Leahey A, Dunkel IJ, Jubran R, Rodriguez-Galindo C, Schmidt M, Weinstein JL..., Int J Cancer, 7/20/2010
• Conjunctival Marginal Zone B-cell Lymphoma in a 13 year old: a Treatment Dilemma.  
  Frankel, S, Gaitonde AA, Azar N, Wood MG, Schmidt ML, Journal of Pediatric Ophthalmology Strabismus, 2/1/2010
• Online Ethics Discussion Forum Facilitates Medical Center Clinical Ethics Case Reviews.  
  Ramsey DJ, Schmidt ML, Anderson-Shaw L, Journal of Nursing Administration’s Healthcare Law, Ethics and Regulation, 1/1/2010
• Control of disseminated intravascular coagulation in Klippel-Trenauney-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report.  
  Beier UH, Schmidt ML, Hast H, Valentino LA, Journal of Medical Case Reports, 1/1/2010
• Prolonged Chronic Phase of Chronic Myeloid Leukemia in a Patient with Congenital Human Immunodeficiency Virus Infection.  
  Setty, BA, Hayani KC, Sharon BI, Schmidt ML, Pediatric Blood and Cancer, 6/1/2009
• Fixing the System not the Women: an innovative approach to faculty advancement.  
  Morrissey CS, Schmidt ML, Journal of Women’s Health, 1/1/2008
• Pediatric Squamous Cell Carcinoma Arising in an Alpha-Fetoprotein-Producing Mature Cystic Teratoma of the Mandible.  
  Cabay RJ, Setty S, Schwartz JL, Yao M, Schmidt ML, Gordon SC, Pediatric Blood and Cancer, 1/1/2008
• Pediatric Squamous Cell Carcinoma Arising in an Alpha-Fetoprotein (AFP)-Producing Cystic Teratoma of the Mandible.  
  Cabay R, Setty S, Schwartz JL, Yao M, Schmidt ML, Goodon SC, Arch Path Lab Med, 9/1/2007
• Hearing Loss, Quality of Life and Academic Problems in Long-Term Neuroblastoma Survivors-A Report From the Children’s Oncology Group.  
  Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML, Pediatrics, 1/1/2007
• Do Parents Have the Right to Refuse Standard Treatment for their child with Favorable Prognosis Cancer?-Ethical and Legal Concerns.  
  Hord JD, Rehman W, Hannon P, Anderson-Shaw L, Schmidt ML, Journal of Clinical Oncology, 12/1/2006
• A novel MLL-SEPT6 fusion transcript in an infant with acute myeloid leukemia.  
  Kadkol SS, Bruno A, Oh S, Schmidt ML, Lundgren V, Cancer Genetics and Cytogenetics, 1/1/2006
• Evolution of a living donor liver transplantation advocacy program.  
  Anderson-Shaw L, Testa G, Schmidt ML, Elkin J, Chamberlin WM, Benedetti E, The Journal of Clinical Ethics, 1/1/2005
• Favorable Prognosis For Patients Ages 12-18 Months with Stage 4 MYCN-Nonamplified Neuroblastoma: A Children’s Cancer Group Study.  
  Schmidt ML, Lal, A, Seeger RC, Maris J, Shimada H, O’Leary M, Gerbing R, Matthay KK, J. Clin. Oncol, 1/1/2005
• The Role of Age in Neuroblastoma Risk Stratification: The German, Italian and Children’s Oncology Group Perspectives.  
  London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B, Cancer Letters, 1/1/2005
• Biologic Factors Determine Prognosis in Infants with Stage IV Neuroblastoma: A Prospective Children’s Cancer Group Study.  
  Schmidt ML, Lukens J, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK, Journal of Clinical Oncology, 1/1/2000
• Synergy between 5’ and 3’ flanking regions of the human tryosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cells.  
  Gardaneh M, Gilbert J, Haber M, Norris MD, Cohn SL, Schmidt ML, Marshall GM, Neuroscience Letters, 1/1/2000
• Differential Expression in an Antisense-MYCN Neuroblastoma (NB) Model.  
  Schmidt ML, Lal A, Dittmann D, Med Pediatr Oncol, 1/1/2000
• p53 Influences Betulinic Acid-induced Apoptosis in Neuroblastoma.  
  Schmidt ML, Ling-Indeck L, Journal of Pediatric Hematology/Oncology, 8/1/1999
• Hepatoblastoma Following Renal Transplantation in a Child with Urinary Tract Anomolies.  
  Amin S, John E, Benedetti E, Radhakrishnan J, Ferrer K, Schey W, Schmidt ML, Journal of Pediatric Hematology/Oncology, 8/1/1999
• Join now to see all

Books/Book Chapters

• In This Side of Doctoring, Reflections from Women in Medicine. 
  Chapter: Finding the balance point between overdrive and the mommy track. 
  Page 205 - 207Schmidt MLEditors: Eliza Chin.Sage Publications, Thousand Oaks, CAA2001
• In This Side of Doctoring, Reflections from Women in Medicine. 
  Chapter: Can it be done? 
  Page 276 - 280Schmidt MLEditors: Eliza Chin.Sage Publications, Thousand Oaks, CAA2001

Abstracts/Posters

• Data-driven Policy Recommendations to Promote the Advancement & Retention of Female Physician, Physician Scientists in the Academic Medicine Pipeline.
  Kwan JM, Daye D, Schmidt ML, Morrissey C, Kim H, Payne A, Quinn K, American Association of Medical Colleges Annual Meeting (Nov 2-7, 2012), 11/2/2012
• Outcome Analysis of Non-High Risk Neuroblastoma Patients Enrolled on Children’s Oncology Group Trials P9641 and A3961.
  Attiyeh E, , Meany H, Naranjo A, Twist C, London W, Villablanca J, Baker D, Strother DR, Schmidt ML, Maris J, Park J, The Advances in Neuroblastoma Research Conference 2012, Toronto, Ont, Canada, 6/21/2012
• Infant Metastatic (4+4S) Non-amplified Neuroblastoma has a very high survival rate with moderate dose chemotherapy.
  Schmidt ML, Strother D, Baker D, Naranjo A, McGrady P, London W, Shimada H, Cohn SL, Matthay KK, Maris J, The Advances in Neuroblastoma Research Conference 2012, Toronto, Ont, Canada (Jun 18-21, 2012), 6/18/2012
• Morbidity and Mortality risks in infants with Stage 4S neuroblastoma: A report from the Children’s Oncology Group study ANBL0531, “Response and Biology-based Therapy ...
  Twist C, London W, Schmidt ML, Cohn SL, Park JR, Maris J, The Advances in Neuroblastoma Research Conference 2012, Toronto, Ont, Canada (Jun 18-21, 2012), 6/18/12
• Outcome analysis of non-high-risk neuroblastoma patients enrolledon Children’s Oncology Group trials P9641 and A3961.
  Meany HJ, Attiyeh EF, Naranjo A, Twist C, London WB, Villablanca J, Schmidt ML, Baker D, Strother DR, Shimada H, Matthay KK, Cohn SL, Maris JM, Park JR, American Society of Clinical Oncology, Chicago, IL, 6/1/2012
• Caring for Children with Neuroblastoma: Biology Determines Survival.
  Schmidt ML, Cancer Cell Signaling Program, UIC Cancer Center, 11/15/2011
• Ototoxicity in childrens with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales-A report from the Children’s Oncology Group.
  Landier W, Knight KR, Wong FL, Lee JK, Thomas O, Kim H, Kreissman SG, Schmidt ML, Chen L, London WB, Bhatia S, Gurney JG, American Society of Clinical Oncology Meeting Chicago, IL, 6/1/2011
• Capillary Hemangiomas treated with Propranolol: A new and exciting innovation in care.
  Schmidt ML, UIC Department of Pediatrics Grand Rounds, 7/16/2010
• Outcome for Stage 3 Neuroblastoma: A Report From The Children’s Oncology Group.
  Park JR, London WB, Schmidt ML, Baker D, Kreissman S, Villablanca JG, Shimada H, Attiyeh E, Hogarty M, Maris JH, Matthay KK, Cohn SL, Advances in Neuroblastoma Research, Sweden, 6/1/2010
• Giving Bad News: Impact on Child Life Therapists.
  Schmidt ML, Chicagoland Child Life Therapy Association, 5/13/2010
• Panel Discussion on Sub-Specialties in Pediatrics
  Schmidt ML, Pediatric Interest Group, UIC, 3/17/2010
• New Approaches to Capillary Hemangiomas.
  Schmidt ML, Illinois Association of Ophthalmology, Rosemont, IL, 2/19/2010
• Pediatric Oncology: Life, Death and The Role of Spiritual Support
  Schmidt ML, Integritas Institute for Ethics, UIC, 2/11/2010
• 107. Why I love being a Physician in the 21st Century.
  Schmidt ML, Society of Future Physicians, UIC, 10/20/2009
• Significance of tumor biology compared to metastatic pattern (INSS 4 vs 4s) and age for prognosis of neuroblastoma less than 18 months of age.
  Taggert, D, London W, Schmidt, ML, Zhang Y, DuBois S, Monclair T, Pearson A, Cohn SL, Matthay KK, American Society of Clinical Oncology Meeting, Orlando, FL, 6/1/2009
• Women and Medicine Panel and Discussion: “Life in the Fast Lane: Insights from the Journeys of Women Physician Scientists”.
  Schmidt ML, American Physician Scientist Association, Chicago, IL, 4/24/2009
• Faith at the bedside for patients with life-threatening conditions.
  Schmidt ML, UIC Catholic Medical Student Association, 3/26/2009
• Disclosure of Poor Prognosis to a 13 y/o with multiply relapsed cancer.
  Schmidt ML, Jewish Medical Ethics Symposium, UIC, 3/18/2009
• Lifestyle Panel
  Schmidt ML, American Medical Women’s Association Region 6 Conference and Research Symposium, UIC, Chicago, IL, 1/18/2009
• Fixing the System, Not the Women
  Schmidt ML, American Medical Women’s Association Region 6 Conference and Research Symposium, UIC, Chicago, IL, 1/17/2009
• Seeking Nirvana: Finding Balance between Personal and Professional Goals.
  Schmidt ML, Kwan J, UIC Undergraduate Honors Seminar, 11/19/2008
• Pediatric Oncology Research: The Impact of Collaborative Clinical Trials
  Schmidt ML, Partnerships 4 Cure Donors Forum, Chicago, IL, 5/15/2008
• Genomic Aberration Patterns Predict Relapse in Low- And Intermediate-Risk Neuroblastoma (NB): A Children’s Oncology Group (COG) Study
  Advances in Neuroblastoma Research meeting, Japan, 5/1/2008
• A Career in Pediatric Oncology
  Schmidt ML, Hematology/Oncology Interest Group, UIC COM, 4/17/2008
• Parity without Power, Chicago Medical Student Campus Leadership Series.
  Schmidt ML, Chicago Medical Student Campus Leadership Series, 3/25/2008
• Join now to see all

Lectures

• Neuroblastoma Research Seminar. 
  Ophthalmology Research Conference, Department of Ophthalmology, University of Illinois at Chicago, - 10/25/1995